Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
03/2010
03/09/2010US7674752 Functional protein arrays
03/09/2010US7674618 Expression vector
03/09/2010US7674607 DNA encoding G+C-rich promoter binding protein
03/09/2010US7674606 Protein isolation
03/09/2010US7674604 Using computer modeling to identify positions where cysteinal insertion will lock protein comprising integrin domain sequences into preferential configuration; directed protein evolution
03/09/2010US7674594 Drug screening; Inhibitors of thymol activation of ion channel TRPA1 can be used to prevent the objectionable taste of thymol in medical uses where taste limits acceptance such as mouthwash
03/09/2010US7674591 Methods of using antibodies to human IL-13bc for inhibiting IL-13 binding
03/09/2010US7674586 Methods of identifying modulators of L-glutamate-gated chloride channel proteins from Rhipicephalus sanguineus
03/09/2010US7674585 Methods, kits and compositions pertaining to combination oligomers and libraries for their preparation
03/09/2010US7674470 Comprises clostridial neurotoxin light chain domains; endopeptidases; vaccines; fusion proteins; for inhibiting exocytosis
03/09/2010US7674463 Method of inhibiting angiogenesis by administration of a corticotropin releasing factor receptor 2 agonist
03/09/2010US7674455 treating a mammal having amyotrophic lateral sclerosis by transducing a motor neuron of the mammal with an insulin-like growth factor I (IGF-1) gene or a glial cell line-derived neurotrophic factor (GDNF) gene; neurodegenerative disorders
03/09/2010US7674291 Generating transgenic cell which express keratinocyte growth factor-2 (KGF-2) for use ase tool in treatment of ulcers and inflammatory bowel disease
03/09/2010CA2419453C Mutant transglutaminase from streptoverticillium having modified substrate specificity
03/09/2010CA2386180C Vectors and methods for recombinant protein expression
03/09/2010CA2382464C High-affinity choline transporter
03/09/2010CA2368994C Preparation of biologically active molecules
03/09/2010CA2342960C G protein-coupled receptor antagonists
03/09/2010CA2264963C Protein markers for esophageal cancer
03/09/2010CA2159702C High molecular and low molecular fractions of von willebrand factor
03/09/2010CA2156007C Purification of alpha-1 proteinase inhibitor using novel chromatographic separation conditions
03/05/2010CA2679676A1 Monoclonal antibodies for neutralizing anthrax toxin
03/04/2010WO2010025421A2 Modulators of myc, methods of using the same, and methods of identifying agents that modulate myc
03/04/2010WO2010025417A1 Genetically engineered g-alpha proteins and uses thereof
03/04/2010WO2010025320A1 Novel hemipteran and coleopteran active toxin proteins from bacillus thuringiensis
03/04/2010WO2010025247A1 Epicatechin glucosyltransferase
03/04/2010WO2010025177A1 Method and compositions for enhanced anti-tumor effector functioning of t cells
03/04/2010WO2010025173A2 Labeled peptides and methods of use thereof for improved oxidation and mapping of disulfide bridges
03/04/2010WO2010024897A2 Methods and compositions for treating prostate cancer or inducing a humoral immune response against prostate cancer
03/04/2010WO2010024776A1 Anln protein as an endocrine treatment predictive factor
03/04/2010WO2010024704A2 A gammacarboxyglutamate-rich protein, methods and assays for its detection, purification and quantification and uses thereof
03/04/2010WO2010024673A1 Radiolabeled annexins
03/04/2010WO2010024269A1 Dwarf transgenic plant, and gene for induction of dwarfing
03/04/2010WO2010023910A1 Method for modifying sugar chain structure in plant, and plant produced by the method
03/04/2010WO2010023850A1 Method for treating or preventing bladder cancer using the depdc1 polypeptide
03/04/2010WO2010023544A1 Compositions and methods for delivery of protein-coding rnas to correct mitochondrial dysfunction
03/04/2010WO2010023440A1 Therapeutic peptides
03/04/2010WO2010023260A1 Vaccine compositions
03/04/2010WO2010023247A1 Synthetic peptides corresponding to overlapping neutralizing determinants in the cbd1 epitope induce broadly neutralizing antibodies.
03/04/2010WO2010023186A1 Nematode-resistant transgenic plants
03/04/2010WO2010022979A1 Clostridial neurotoxins with altered persistency
03/04/2010WO2010022946A1 Method for reducing the viral and microbial load of biological extracts containing solids
03/04/2010WO2010022808A1 Method for reducing the viral and microbial load of biological extracts containing solids
03/04/2010WO2010022740A2 Hiv-1 envelope polypeptides for hiv vaccine
03/04/2010WO2010022727A1 INFECTIOUS GENOTYPE 1a, 1b, 2a, 2b, 3a, 5a, 6a and 7a HEPATITIS C VIRUS LACKING THE HYPERVARIABLE REGION 1 (HVR1)
03/04/2010WO2010022463A1 Prevention, treatment and diagnosis of p.gingivalis infection
03/04/2010WO2010022462A2 Mutant bacterial glycoproteins and uses thereof
03/04/2010WO2010022452A1 Methods and compositions for treating and preventing malaria using an invasion ligand directed to a protease-resistant receptor
03/04/2010WO2010022443A1 Resistance genes
03/04/2010WO2010006296A3 New avian bornavirus
03/04/2010WO2010005515A3 Expression methods for guanylate cyclase c receptor binding polypeptides
03/04/2010WO2010000849A3 Conserved secreted proteins from protozoan parasites
03/04/2010WO2009158015A3 Antagonists of actriib and uses for increasing red blood cell levels
03/04/2010WO2009156179A8 Her3 as a determinant for the prognosis of melanoma
03/04/2010WO2009152986A8 Muc16 fragments with antigenic activity and pharmaceutical compositions thereof
03/04/2010WO2009140132A9 Novel bacillus thuringiensis gene with lepidopteran activity
03/04/2010WO2009139599A3 Cell-permeable p27 recombinant protein, a polynucleotide that codes the same and an anti-cancer composition containing the same as an active ingredient
03/04/2010WO2009134428A3 Methods and compositions based on alk1 antagonists for modulating angiogenesis and pericyte coverage
03/04/2010WO2009111701A3 Method of treating t cell mediated disorders
03/04/2010WO2009109532A9 Use of defensins against tuberculosis
03/04/2010WO2009023955A8 Cytotoxicity mediation of cells evidencing surface expression of cd9
03/04/2010WO2009003977A9 Plants having enhanced yield-related traits and a method for making the same
03/04/2010WO2008103044A8 Non-natural recombinant gelatins with enhanced functionality
03/04/2010WO2007102686A8 Peptides having activities of insulin like growth factor-1 and their uses
03/04/2010US20100058488 Protein formulations comprising s1-5
03/04/2010US20100056757 Clarification of transgenic milk using depth filtration
03/04/2010US20100056488 Corticosteroid conjugates and uses thereof
03/04/2010US20100056459 Cell-Permeable Peptide Inhibitors of the JNK Signal Transduction Pathway
03/04/2010US20100056455 Therapies Which Act on Neuropeptide S Receptors
03/04/2010US20100056454 Method for Screening Modulators of Apoptosis
03/04/2010US20100056452 Angiogenesis-promoting substrate
03/04/2010US20100056448 Glut-1 as a receptor for htlv envelopes and its uses
03/04/2010US20100056447 Immunization against chlamydia pneumoniae
03/04/2010US20100056443 Radiopharmaceutical to be used in distinction between inflammations and infections in orthopaedic implants
03/04/2010US20100056442 Use of gpr101 receptor in methods to identify modulators of hypothalamic proopiomelanocortin (pomc)-derived biologically active peptide secretion useful in the treatment of pomc-derived biologically
03/04/2010US20100056439 Ligands that have binding specificity for egfr and/or vegf and methods of use therefor
03/04/2010US20100056438 Methods of producing nano-and microcapsules of spider silk proteins
03/04/2010US20100056428 Modified proteins
03/04/2010US20100055797 Nano-construction processes and analytical processes
03/04/2010US20100055778 Mammalian zcytor 11
03/04/2010US20100055763 Method for the production and purification of retroviral vectors
03/04/2010US20100055728 Enzyme sensors, methods for preparing and using such sensors, and methods of detecting protease activity
03/04/2010US20100055715 Nucleic and amino acid sequences of prokaryotic ubiquitin-like protein and methods of use thereof
03/04/2010US20100055709 Tubulin Mutation Diagnostic
03/04/2010US20100055696 DRG11-Responsive (DRAGON) Gene Family
03/04/2010US20100055687 Mutations in the BCR-ABL tyrosine kinase associated with resistance to ST1-571
03/04/2010US20100055669 Generation of Recombinant Genes in Bacteriophages
03/04/2010US20100055506 Newly Discovered Bacterium in the Family Acetobacteraceae
03/04/2010US20100055438 Concentrated aqueous silk fibroin solution and use thereof
03/04/2010US20100055184 Hydrogels for vocal cord and soft tissue augmentation and repair
03/04/2010US20100055164 Synthetic lung surfactant and use thereof
03/04/2010US20100055150 Method and composition for treatment of skeletal dysplasias
03/04/2010US20100055134 Method of separating protective components of bordetella pertussis
03/04/2010US20100055130 Staphylococcus aureus proteins and nucleic acids
03/04/2010US20100055129 Modulators of myc, methods of using the same, and methods of indentifiying agents that modulate myc
03/04/2010US20100055127 Procedure For Expressing A Tbpb Protein On The Bacterial Surface Of An Attenuated Oral Live Vaccine As Prototype Of A Meningitis B Vaccine
03/04/2010US20100055126 Methamphetamine-like hapten compounds, linkers, carriers and compositions and uses thereof
03/04/2010US20100055124 BRACHYSPIRA PILOSICOLI 72kDa OUTER-MEMBRANE PROTEIN AND DIAGNOSTIC AND THERAPEUTIC USES THEREOF
03/04/2010US20100055123 Vaccine against burkholderia infections
03/04/2010US20100055122 Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof
1 ... 537 538 539 540 541 542 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 ... 2916